150 related articles for article (PubMed ID: 23225077)
1. Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis.
Vachvanichsanong P; Dissaneewate P; McNeil E
Int Urol Nephrol; 2013 Oct; 45(5):1301-8. PubMed ID: 23225077
[TBL] [Abstract][Full Text] [Related]
2. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
[TBL] [Abstract][Full Text] [Related]
3. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
Igarashi T; Igarashi T; Shimizu A; Itoh Y
J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
7. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
Yamaji K; Kim YJ; Tsuda H; Takasaki Y
Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
[TBL] [Abstract][Full Text] [Related]
9. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
Contreras G; Tozman E; Nahar N; Metz D
Lupus; 2005; 14 Suppl 1():s33-8. PubMed ID: 15803929
[TBL] [Abstract][Full Text] [Related]
10. The long-term prognosis of lupus nephritis patients treated with intravenous cyclophosphamide.
Matsuyama N; Morimoto S; Tokano Y; Amano H; Nozawa K; Isonuma H; Hashimoto H; Takasaki Y
Intern Med; 2010; 49(9):823-8. PubMed ID: 20453401
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
12. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
Opastirakul S; Chartapisak W
Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
[TBL] [Abstract][Full Text] [Related]
13. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
[TBL] [Abstract][Full Text] [Related]
14. Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial.
Zheng Z; Zhang H; Peng X; Zhang C; Xing C; Xu G; Fu P; Ni Z; Chen J; Xu Z; Zhao MH; Li S; Huang X; Miao L; Chen X; Liu B; He Y; Li J; Liu L; Kadeerbai H; Liu Z; Liu Z
JAMA Netw Open; 2022 Mar; 5(3):e224492. PubMed ID: 35353167
[TBL] [Abstract][Full Text] [Related]
15. Treatment of proliferative lupus nephritis: a changing landscape.
Adu D
Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
[TBL] [Abstract][Full Text] [Related]
16. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
17. Long-term renal outcome and complications in South Africans with proliferative lupus nephritis.
Ayodele OE; Okpechi IG; Swanepoel CR
Int Urol Nephrol; 2013 Oct; 45(5):1289-300. PubMed ID: 23306862
[TBL] [Abstract][Full Text] [Related]
18. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
20. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY
Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]